Unconjugated belantamab antibody and belantamab mafodotin clinical trials

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

This study looks at a new treatment called belantamab for multiple myeloma, a type of blood cancer. We want to see how safe it is and how well it works, both on its own and when combined with other medicines. It's for people whose myeloma has come back or hasn't responded to previous treatments.